Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
PapasliotiEMParviainenARomn AlpisteMJMarchesiCGarridoCJ.Quantification of potentially toxic elements in food material by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) via pressed pellets
1 ,2 About the REDEFINE 1 trial REDEFINE 1 was a double-blind, placebo-and active-controlled 68-week efficacy and safety phase 3 trial of once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg), cagrilintide 2.4 mg monotherapy and semaglutide 2.4 mg monotherapy versus placebo in 3,417 adults with obesity (BMI 30 kg/m 2 ), or overweight (BMI 27 kg/m 2 ) with one or more obesity-related comorbidities, and without type 2 diabetes
Drug Discovery: Screen for compounds that modulate GPx activity as potential therapeutics for oxidative stress-related diseases
Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant
US$ 20.44
US$ 26.89
US$ 24.46
US$ 27.36
US$ 27.27